Zivo Bioscience

Zivo Bioscience Current Assets

The Current Assets of Zivo Bioscience (ZIVO) as of Oct 21, 2026 is 401,336.00 USD. In the previous year, Current Assets was 1.64 M USD — a change of -75.46% (lower).

Current Assets

401,336.00USD

YoY

-75.46%

Last updated:

Current Assets of Zivo Bioscience is 2025 401,336.00 USD. Current Assets of Zivo Bioscience was 2024 1.64 M USD. It decreases by -75.46% lower compared to the previous year.

The Zivo Bioscience Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 2018
411,506.00 USD
Jan 1, 2019
369,393.00 USD
Jan 1, 2020
167,815.00 USD
Jan 1, 2021
8.96 M USD
Jan 1, 2022
1.90 M USD
Jan 1, 2023
425,342.00 USD
Jan 1, 2024
1.64 M USD
Jan 1, 2025
401,336.00 USD
The Zivo Bioscience Current Assets history
YEARCurrent AssetsYoY
401,336.00USD-75.46%
1.64 MUSD+284.50%
425,342.00USD-77.63%
1.90 MUSD-78.78%
8.96 MUSD+5,239.18%
167,815.00USD-54.57%
369,393.00USD-10.23%
411,506.00USD+23.84%
332,278.00USD-36.15%
520,423.00USD+1,698.90%
28,930.00USD-12.62%
33,107.00USD-94.19%
570,060.00USD+527.78%
90,805.00USD-63.65%
249,830.00USD+575.00%
37,012.00USD-64.52%
104,321.00USD-3.85%
108,494.00USD+246.22%
31,337.00USD-41.21%
53,305.00USD-91.42%
621,370.00USD+1,950.52%
30,303.00USD+226.19%
9,290.00USD—
0.00USD—
0.00USD—
0.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Zivo Bioscience Stock analysis

What does Zivo Bioscience do? Zivo Bioscience, Inc. generates revenue by developing and selling natural bioactive ingredients derived from its proprietary algal strains to manufacturers in the animal, human, dietary supplement, and medical food industries. The company focuses on research and identification of bioactive molecules for use in products targeting autoimmune and inflammatory response modulation. It also develops and sells health optimization tests that help users identify future health risks and personalize their wellness approaches. The firm manufactures algal products and derivatives through its proprietary platforms, serving both human and animal health markets. The company's primary customers include manufacturers of dietary supplements, medical foods, and pharmaceuticals seeking natural ingredients for their formulations. These manufacturers utilize Zivo's bioactive molecules to create products that address autoimmune and inflammatory conditions. Additionally, the company's health optimization tests are marketed to consumers interested in proactive health management, offering personalized insights based on bioactive data. Zivo's product portfolio spans from raw ingredients to finished test kits, all derived from its algal and bacterial host cultures. Zivo Bioscience's revenue streams are built around its proprietary algal strains, which serve as the foundation for all its products. The company's focus on natural compounds and bioactive molecules allows it to target both the supplement and medical food sectors, as well as the emerging market for personalized health diagnostics. By leveraging its research capabilities, Zivo provides specialized ingredients and diagnostic tools that cater to specific health challenges, particularly those related to immune response and inflammation. The firm's business model centers on creating value through scientific innovation in natural product development and health monitoring technologies. Zivo Bioscience is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Zivo Bioscience stock

Current Assets of Zivo Bioscience is 401,336.00 USD in 2025.

Current Assets of Zivo Bioscience changed from 1.64 M USD to 401,336.00 USD, representing a -75.46% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Assets Zivo Bioscience since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's Zivo Bioscience historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Zivo Bioscience

All Key Metrics — Zivo Bioscience